Skip to main content
. 2016 Jul 20;19(7):445–452. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2016.07.06

2.

诱导治疗组和直接手术组临床病理特征(剔除Masaoka-Koga Ⅳ期病例)

Patients' characteristics of Masaoka-Koga stage Ⅲ in the DS group and those of pathological Masaoka-Koga stage Ⅰ-Ⅲ in the IT group

Variables IT(n=55) DS(n=499) P value
IT: Induction therapies; DS: Directly surgery; C: Carcinoma; NETT: Neuroendocrine thymic tumor.
注:本表得到版权所有者©2011-2016 Journal of Thoracic Disease复制许可。
Gender 0.941
  Male 34(61.8%) 311(62.3%)
  Female 21(38.2%) 188(37.7%)
Age(yr, mean±SD) 45.3±14.7 51.6±13 0.135
Tumor size(cm, mean±SD) 7.96±2.7 7.92±3.2 0.224
Preoperative MG 0.000
  No 50(90.9%) 379(76%)
  Yes 5(9.1%) 120(24%)
WHO histological types 0.332
  A 2(3.6%) 10(2%)
  AB 5(9.1%) 40(8%)
  B1 4(7.3%) 40(8%)
  B2 4(7.3%) 40(8%)
  B3 11(20%) 140(28.1%)
  C 28(50.9%) 183(36.7%)
  NETT 1(1.8%) 16(3.2%)
WHO histological types(combination) 0.022
  Thymoma 26(47.3%) 300(60.1%)
  C+NETT 29(52.7%) 199(39.9%)
Resection State 0.63
  R0 42(76.4%) 366(73.3%)
  R1+R2 13(23.6%) 133(26.7%)